- cafead Apr 15, 2024 at 09:53: PM
via After nearly two years of legal back and forth, Pfizer and its German partner BioNTech have won a brief reprieve in their patent fight against mRNA rival Moderna.
In a docket entry dated Friday, Massachusetts federal judge Richard G. Stearns granted a stay on the case to provide more time for the Patent Trial and Appeal Board (PTAB) to review challenges against two of the three relevant patents in the litigation.
article source
In a docket entry dated Friday, Massachusetts federal judge Richard G. Stearns granted a stay on the case to provide more time for the Patent Trial and Appeal Board (PTAB) to review challenges against two of the three relevant patents in the litigation.
article source